| 2023年中报 | |
|---|---|
| 营业收入(元) | |
| 药用口服级大豆磷脂(元) | 4,399,907.62 |
| 药用注射级大豆磷脂(元) | 1,005,316.38 |
| 营业成本(元) | |
| 药用口服级大豆磷脂(元) | 2,143,708.86 |
| 药用注射级大豆磷脂(元) | 627,950.47 |
| 毛利(元) | |
| 药用口服级大豆磷脂(元) | 2,256,198.76 |
| 药用注射级大豆磷脂(元) | 377,365.91 |
| 毛利率(%) | |
| 药用口服级大豆磷脂(%) | 51.28 |
| 药用注射级大豆磷脂(%) | 37.54 |
| 收入构成(%) | |
| 药用口服级大豆磷脂(%) | 81.40 |
| 药用注射级大豆磷脂(%) | 18.60 |
| 毛利构成(%) | |
| 药用口服级大豆磷脂(%) | 85.67 |
| 药用注射级大豆磷脂(%) | 14.33 |